about
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a no...
Read More
7.41
0.13
(1.79%)
11,555
XNAS Volume
XNAS 07 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Instil Bio Inc is on 13 Aug 2026 for the purpose of Instil Bio Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Instil Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..